Hepion Pharmaceuticals, Inc.
HEPA· OTC
HEPAHepion Pharmaceuticals, Inc.
Filed Nov 14, 2019 · 10-Q · 45 days after period end · 0001104659-19-064342
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2014 |
|---|---|---|---|---|
| Net Income | -$1.82M | -$157.06K | -$5.77M | -$9.31M |
| EPS Diluted | -$0.53 | -$44.27 | -$0.77 | -$0.63 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Hepion Pharmaceuticals, Inc. · CIK 1583771 · Engraved from SEC EDGAR
ended Sep 30, 2019 · filed Nov 14, 2019 · 45 d after period end
